Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$95,954
+$19,614 QoQ
Shares Held
80
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#4,487
of 4,605 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marquette Asset Management, LLC holds $545,493 across 9 Drug Manufacturers - General names. LLY ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
935 | $237,461 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
80 | $95,954 | |
| 3 | AMGN |
Amgen Inc
|
185 | $66,992 | |
| 4 | MRK |
Merck & Co., Inc.
|
379 | $48,701 | |
| 5 | ABBV |
AbbVie Inc.
|
140 | $35,229 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
214 | $27,036 | |
| 7 | PFE |
Pfizer Inc
|
832 | $20,034 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
132 | $7,605 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,954 | 80 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $76,340 | 83 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $77,376 | 72 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $53,410 | 70 | Shares | Sole | 2025-10-24 | |
| 2023-09-30 | $14,502 | 27 | Shares | Other | 2023-10-27 | |
| 2023-06-30 | $14,069 | 30 | Shares | Other | 2023-07-28 | |
| 2022-06-30 | $1,296 | 4 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,145 | 4 | Shares | Sole | 2022-04-26 | |
| No filing history on record for this holder in this stock. | ||||||